98-20305. ``Draft Compliance Program Guidance Manual: Inspection of Medical Device Manufacturers;'' Availability  

  • [Federal Register Volume 63, Number 146 (Thursday, July 30, 1998)]
    [Notices]
    [Pages 40720-40721]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 98-20305]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    [Docket No. 98D-0449]
    
    
    ``Draft Compliance Program Guidance Manual: Inspection of Medical 
    Device Manufacturers;'' Availability
    
    AGENCY: Food and Drug Administration, HHS.
    
    ACTION: Notice.
    
    -----------------------------------------------------------------------
    
    SUMMARY: The Food and Drug Administration (FDA) is announcing the 
    availability of a draft document entitled ``Draft Compliance Program 
    Guidance Manual: Inspection of Medical Device Manufacturers.'' This 
    draft guidance provides guidance to the FDA field staff for the 
    enforcement of the requirements of the quality system regulation, and 
    it includes guidance on the amendments to the quality system 
    regulation, which became effective June 1, 1997. This draft guidance is 
    intended to represent the agency's current thinking on inspection of 
    medical device manufacturers, and it is not final nor is it in effect 
    at this time.
    
    DATES: Written comments may be provided at any time, however, comments 
    should be submitted by October 28, 1998.
    ADDRESSES: Submit written requests for single copies on a 3.5'' 
    diskette of the guidance document entitled ``Draft Compliance Program 
    Guidance Manual: Inspection of Medical Device Manufacturers'' to the 
    Division of Small Manufacturers Assistance (HFZ-220), Center for 
    Devices and Radiological Health, Food and Drug Administration, 1350 
    Piccard Dr., Rockville, MD 20850. Send one self-addressed adhesive 
    label to assist that office in processing your request, or fax your 
    request to 301-443-8818. See the SUPPLEMENTARY INFORMATION section for 
    information on electronic access to the guidance.
        Submit written comments on the document to the Dockets Management 
    Branch (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 
    1061, Rockville, MD 20852.
    
    FOR FURTHER INFORMATION CONTACT: Wes W. Morgenstern, Center for Devices 
    and Radiological Health (HFZ-305), Food and Drug Administration, 9200 
    Corporate Blvd., Rockville, MD 20850, 301-594-4699.
    
    SUPPLEMENTARY INFORMATION:
    
    I. Background
    
        FDA is announcing the availability of a draft document entitled 
    ``Draft Compliance Program Guidance Manual: Inspection of Medical 
    Device
    
    [[Page 40721]]
    
    Manufacturers'' (CP 7382.830). This draft document provides guidance to 
    the FDA field staff for the enforcement of the quality system 
    regulation (part 820 (21 CFR part 820)). This draft is a revision to 
    the document first made available in May 1995, in accordance with the 
    amendments to part 820, effective June 1, 1997.
        This guidance document represents the agency's current thinking on 
    inspection of medical device manufacturers. It does not create or 
    confer any rights for or on any person and does not operate to bind FDA 
    or the public. An alternative approach may be used if such approach 
    satisfies the applicable statute, regulations, or both.
        The agency has adopted Good Guidance Practices (GGP's), which set 
    forth the agency's policies and procedures for the development, 
    issuance, and use of guidance documents (62 FR 8961, February 27, 
    1997). This draft guidance document is issued as a Level 1 guidance 
    consistent with GGP's.
    
    II. Electronic Access
    
        In order to receive the ``Draft Compliance Program Guidance Manual: 
    Inspection of Medical Device Manufacturers'' (CP 7382.830) via your fax 
    machine, call the CDRH Facts-On-Demand (FOD) system at 800-899-0381 or 
    301-827-0111 from a touch-tone telephone. At the first voice prompt 
    press 1 to access DSMA Facts, at second voice prompt press 2, and then 
    enter the document number (487) followed by the pound sign 
    (). Then follow the remaining voice prompts to 
    complete your request.
        Persons interested in obtaining a copy of the draft guidance may 
    also do so using the World Wide Web (WWW). CDRH maintains an entry on 
    the WWW for easy access to information including text, graphics, and 
    files that may be downloaded to a personal computer with access to the 
    Web. Updated on a regular basis, the CDRH home page includes the 
    ``Draft Compliance Program Guidance Manual: Inspection of Medical 
    Device Manufacturers'' (CP 7382.830), device safety alerts, Federal 
    Register reprints, information on premarket submissions (including 
    lists of approved applications and manufacturers' addresses), small 
    manufacturers' assistance, information on video conferencing and 
    electronic submissions, mammography matters, and other device-oriented 
    information. The CDRH home page may be accessed at ``http://
    www.fda.gov/cdrh''. The ``Draft Compliance Program Guidance Manual: 
    Inspection of Medical Device Manufacturers'' (CP 7382.830) will be 
    available at ``http://www.fda.gov/cdrh/ochome.html''.
        A text-only version of the CDRH Web site is also available from a 
    computer or VT-100 compatible terminal by dialing 800-222-0185 
    (terminal settings are 8/1/N). Once the modem answers, press Enter 
    several times and then select menu choice 1: FDA BULLETIN BOARD 
    SERVICE. From there follow instructions for logging in, and at the BBS 
    TOPICS PAGE, arrow down to the FDA home page (do not select the first 
    CDRH entry). Then select Medical Devices and Radiological Health. From 
    there select CENTER FOR DEVICES AND RADIOLOGICAL HEALTH for general 
    information, or arrow down for specific topics.
    
    II. Comments
    
        This draft document is being distributed for comment purposes only 
    and is not intended for implementation at this time. Interested persons 
    may submit to Dockets Management Branch (address above) written 
    comments regarding this draft guidance document. Written comments may 
    be submitted at any time, however, comments should be submitted by 
    October 28, 1998, to ensure adequate consideration in preparation of 
    the final document. Two copies of any comments are to be submitted, 
    except individuals may submit one copy. Comments should be identified 
    with the docket number found in brackets in the heading of this 
    document. A copy of the document and received comments are available 
    for examination in the the Dockets Management Branch between 9 a.m. and 
    4 p.m., Monday through Friday.
    
        Dated: July 17, 1998.
    D.B. Burlington,
    Director, Center for Devices and Radiological Health.
    [FR Doc. 98-20305 Filed 7-29-98; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Published:
07/30/1998
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
98-20305
Dates:
Written comments may be provided at any time, however, comments should be submitted by October 28, 1998.
Pages:
40720-40721 (2 pages)
Docket Numbers:
Docket No. 98D-0449
PDF File:
98-20305.pdf